Endobronchial brachytherapy.
High-dose rate endobronchial brachytherapy is a well-tolerated out-patient procedure that provides a high likelihood for durable palliation of symptoms associated with endobronchial tumor. The most significant associated toxicity is late massive hemoptysis, the risk for which can be minimized by careful treatment planning and limiting the size of the delivered dose per fraction to less than 10 Gy, prescribed at 1 cm distance.